Skip to Main Content
Hospital Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • NABP
    • Additional Requirements
    • Exemptions
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • FAQs
    • Enterprise Admin Support
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Just Launched! RxAdvanced hospital competency training for pharmacists and PTU Elite: Immunizations pharmacy technician training program. Get a quote.

  1. Home
  2. Browse
  3. Gastroenterology
  4. Liver Disease
  5. Hepatitis C

Hepatitis C

  • Bowel Preps (5)
  • Celiac Disease (3)
  • Constipation (28)
  • Crohn's Disease (3)
  • Diarrhea (44)
  • Gallbladder (2)
  • Gastrointestinal Bleeding (98)
  • GERD (39)
  • Heartburn (10)
  • Inflammatory Bowel Disease (2)
  • IBS (9)
  • Liver Disease (78)
    • Hepatitis C (36)
    • Natural Medicines / Supplements (3)
    • Drug-Induced Liver Disease (32)
    • Monitoring (16)
  • Nausea & Vomiting (34)
  • Other (71)
  • Peptic Ulcer Disease (30)
  • Resources (100)
  • Ulcerative Colitis (3)
  • Ulcers (7)
1 - 15 of 36 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Using Common Medications in Liver Impairment April 2021
Article: Try to Limit Interruptions of Hep C Antivirals February 2020
Article: Consider the Many Drug Interactions With Hep C Antivirals November 2019
Chart: Guide for Helping Patients Afford Their Medications July 2019
Chart: Hepatitis C Treatment Overview July 2019
Chart: Outpatient Alcohol Detox and Relapse Prevention February 2019
FAQ: Decompensated Chronic Liver Failure August 2018
Chart: Summary Sexually Transmitted Disease Guidelines (CDC, 2015) July 2018
Article: Get Ready for Hep C Meds Mavyret and Vosevi October 2017
Article: Optimize Meds for Comorbidities in Nonalcoholic Fatty Liver Disease September 2017
Commentary: Overview of Nonalcoholic Fatty Liver Disease September 2017
PL Voices: Management of Nonalcoholic Fatty Liver Disease September 2017
Article: Put Warnings About Liver Damage With Hep C Meds Into Perspective April 2017
Other: Hepatitis C Drugs and Risk of Hep B Reactivation April 2017
Article: Discourage Using PPIs With New Hep C Med Epclusa September 2016
  • 1
  • 2
  • 3
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved